Literature DB >> 12115215

Abnormal T cell signal transduction in systemic lupus erythematosus.

Gary M Kammer1, Andras Perl, Bruce C Richardson, George C Tsokos.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12115215     DOI： 10.1002/art.10192

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  39 in total

1.  Drugs, sun and T cells in lupus.

Authors:  G C Tsokos
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 2.  T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens.

Authors:  Syamal K Datta; Li Zhang; Luting Xu
Journal:  J Mol Med (Berl)       Date:  2005-01-04       Impact factor: 4.599

Review 3.  Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases.

Authors:  Stephanie M Stanford; Tomas M Mustelin; Nunzio Bottini
Journal:  Semin Immunopathol       Date:  2010-03-04       Impact factor: 9.623

Review 4.  Epigenetic mechanisms in lupus.

Authors:  Dipak R Patel; Bruce C Richardson
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

5.  Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus.

Authors:  K O Kong; A W Tan; B Y H Thong; T Y Lian; Y K Cheng; C L Teh; E T Koh; H H Chng; W G Law; T C Lau; K P Leong; B P Leung; H S Howe
Journal:  Clin Exp Immunol       Date:  2009-01-23       Impact factor: 4.330

6.  Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus.

Authors:  Stella A Nicolaou; Peter Szigligeti; Lisa Neumeier; Susan Molleran Lee; Heather J Duncan; Shashi K Kant; Anne Barbara Mongey; Alexandra H Filipovich; Laura Conforti
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

7.  Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus.

Authors:  Charles S Via; Gene M Shearer
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

8.  Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosus.

Authors:  Stella A Nicolaou; Lisa Neumeier; Koichi Takimoto; Susan Molleran Lee; Heather J Duncan; Shashi K Kant; Anne Barbara Mongey; Alexandra H Filipovich; Laura Conforti
Journal:  Cell Calcium       Date:  2009-12-02       Impact factor: 6.817

9.  CD3Z hypermethylation is associated with severe clinical manifestations in systemic lupus erythematosus and reduces CD3ζ-chain expression in T cells.

Authors:  Kyeong-Man Hong; Hyun-Kyoung Kim; Seong-Yeol Park; Shiv Poojan; Mi-Kyung Kim; Joohon Sung; Betty P Tsao; Jennifer M Grossman; Ornella J Rullo; Jennifer M P Woo; Deborah K McCurdy; Lisa G Rider; Frederick W Miller; Yeong-Wook Song
Journal:  Rheumatology (Oxford)       Date:  2017-03-01       Impact factor: 7.580

10.  Immunosuppressive therapy modulates T lymphocyte gene expression in patients with systemic lupus erythematosus.

Authors:  Elayne Pereira; Márcia Cristina Tamia-Ferreira; Renato Sousa Cardoso; Stephano Spanó Mello; Elza Tiemi Sakamoto-Hojo; Geraldo A S Passos; Eduardo Antonio Donadi
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.